Syncona

Syncona is a British closed-ended life science investment trust that was established by the Wellcome Trust in 2012, before listing on the London Stock Exchange following a merger with the Battle Against Cancer Investment Trust in December 2016. The firm builds and funds a portfolio of life science companies focused on translating frontier science into transformative therapeutics, spanning pre-clinical through to commercial-stage businesses. Syncona Investment Management Limited operates as the investment manager from its London headquarters.